-
CLAIMS DATA FOR POST-MARKET SAFETY INVESTIGATIONS: LESSONS FROM A REAL-WORLD ONCOLOGY COHORT
Mar 18, 2026, 21:38 PM -
A STATISTICAL MODELING FRAMEWORK FOR PROCESS-MINED REAL-WORLD DATA SUPPORTING HTA OF MULTIPLE MYELOMA TECHNOLOGIES IN A BRAZILIAN HEALTH MAINTENANCE ORGANIZATION
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF HERPES ZOSTER IN IMMUNOCOMPETENT OLDER ADULTS IN THE UNITED STATES: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
GENERIC ENTRY AND THE EARLY IMPACT ON U.S. PHARMACEUTICAL SPENDING
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF INTENSIVE VERSUS STANDARD HYPERTENSIVE THERAPY AMONG TYPE 2 DIABETIC PATIENTS WITH HYPERTENSION
Mar 18, 2026, 21:38 PM -
FINANCIAL COSTS OF PROVIDING ORAL PRE- AND POST-EXPOSURE PROPHYLAXIS VIA PHARMACIES IN KENYA
Mar 18, 2026, 21:38 PM -
TARGETED LITERATURE REVIEW TO IDENTIFY US CLAIMS-BASED ALGORITHMS FOR ALZHEIMER’S DISEASE
Mar 18, 2026, 21:38 PM -
INCREASING EFFICIENCY OF SYSTEMATIC LITERATURE REVIEWS: ARE MULTIPLE DATABASES NECESSARY?
Mar 18, 2026, 21:38 PM -
REAL-WORLD DOSING AND DISCONTINUATION OF HYPERTENSION THERAPIES: INSIGHTS FROM A NATIONAL PHARMACY DATABASE
Mar 18, 2026, 21:38 PM -
VALIDATION OF THE HEPARIN-INDUCED THROMBOCYTOPENIA DIAGNOSIS CODE USING A LARGE-SCALE ELECTRONIC HEALTH RECORD DATABASE
Mar 18, 2026, 21:38 PM -
IMPACT OF LIPID-LOWERING THERAPIES ON TRIGLYCERIDE LEVELS IN US PATIENTS WITH ASCVD IN THE REAL-WORLD
Mar 18, 2026, 21:38 PM -
ATTRIBUTE MINING FOR DISCRETE CHOICE EXPERIMENTS ACROSS DISEASES USING GEN-AI: REPLICATION AND VALIDATION OBJECTIVES
Mar 18, 2026, 21:38 PM -
COMPARISON OF GUIDELINE-RECOMMENDED AND PRELIMINARY RISK-BASED APPROACHES TO SELECTION OF LUNG CANCER PATIENTS FOR LYMPH NODE STAGING
Mar 18, 2026, 21:38 PM -
COMPARISON OF 5-YEAR SURVIVAL AND ESTIMATED LIFE YEARS BETWEEN TWO DATA CUTS OF STUDY 309/KEYNOTE-775
Mar 18, 2026, 21:38 PM -
EVALUATING PATIENT REPORTING HABITS IN CLINICAL TRIALS: A COMPARISON OF EVENT-DRIVEN VS. PROMPTED EVENING EDIARY ENTRIES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF ABIRATERONE, APALUTAMIDE, ENZALUTAMIDE, AND DOCETAXEL DOUBLETS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER: A REAL-WORLD EVIDENCE ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF TIRZEPATIDE FOR THE MANAGEMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY
Mar 18, 2026, 21:38 PM -
FROM TOKYO TO WASHINGTON: IMPACT OF JAPAN’S HTA ENVIRONMENT ON U.S. MFN PRICING AND LAUNCH STRATEGY
Mar 18, 2026, 21:38 PM -
REAL-TIME AND SHORT RECALL OF FLARES IN PNH, CAPTURED THROUGH LONGITUDINAL HOME-REPORTED OUTCOMES
Mar 18, 2026, 21:38 PM -
THE COST OF PERFORMING FEES: ESTIMATING ANNUALIZED COSTS OF MOBILE FEES PROVIDERS FOR LTACH AND SNFS
Mar 18, 2026, 21:38 PM
